On Thursday, the U.S. Food and Drug Administration (FDA) approved Merck & Co Inc.’s MRK LIPFENDRA (enlicitide) as an adjunct ...

Heart experts say that everyone should have their levels of lipoprotein (a), or Lp(a), measured routinely at least once in life, following research from one of the most populous EU countries, Poland, ...

The Family Heart Foundation, a leading research and advocacy organization focused on the role of lipids in cardiovascular disease and prevention, today announced results from the largest study ever ...

A simple blood test for lipoprotein(a), or LP(a), could help identify a major hidden risk for heart attacks and strokes, but ...

When people think about cholesterol and heart health, they usually focus on total cholesterol and LDL levels. Doctors often recommend statins to lower these numbers and reduce heart disease risk. But ...

Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Diazyme Lipoprotein(a) Molarity Assay. This clearance enables clinical ...

A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A.

Thirty-year outcomes among participants in the Women's Health Study showed a stepwise increase in major cardiovascular events associated with increasing lipoprotein(a) levels starting around 30-60 ...

In adults without prior coronary artery disease at the time of imaging, elevated lipoprotein(a) (Lp[a]) levels (≥ 150 nmol/L) were independently associated with increased non-calcified plaque volume ...